Insurance

Allstate’s recent insider trades reveal how AI‑driven risk scoring, climate‑resiliency standards and cyber‑coverage shifts are reshaping U.S. P&C underwriting, offering investors a data‑rich guide to assess profitability, capital efficiency and ESG …

CEO’s structured 10b5‑1 sales at Hippo Holdings reveal a disciplined exit strategy amid a price dip—analyzing what it means for investor confidence and future growth.

Insightful look at Ahn Kenneth’s insider trades at Hagerty Inc.: why the president’s modest buys signal confidence in the company’s future growth.

eHealth Inc. insider sales reveal cautious management amid sharp stock drops—learn what this means for future growth and investor confidence.

Analyze Lincoln National’s risk, actuarial trends, and regulation to explain how insider moves reflect market exposure, AI underwriting, and cyber‑risk capital shifts.

Insider buying at $5.26 shows Lemonade’s chief insurance officer backs the AI‑powered model—a signal that management sees value amid volatility and upcoming expansion.

Oscar Health insider buys signal confidence in its tech‑driven growth, but investors should watch earnings, enrollment and new partnerships for long‑term value.

CEO Dean Strable‑Soethout sells 300 Principal Financial shares under a Rule 10b5‑1 plan – a routine, rule‑compliant move that signals steady management confidence without altering the company’s strategy.

MSI’s disciplined 10b5‑1 purchases of W R Berkley shares show insider confidence and could signal upside for the insurer’s valuation.

Allstate insider Gupta Suren’s matched‑transaction trade shows a savvy, low‑risk strategy—buying at $62.32 and selling at $210.00 for a $147 spread—offering investors a rare insight into executive confidence and potential signals of company directio…